Author

Joshua W. Garton

Oklahoma Medical Research FoundationORCID 0000-0002-4549-1224Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Assay:flow cytometry· 1 Organism:mouse· 1

Frequent Co-Authors

Abigael P. WilliamsiD· 1 shared Anna Karlik· 1 shared Carol F. WebbiD· 1 shared Christopher D. SchareriD· 1 shared David A. FoxiD· 1 shared Dean E. Draayer· 1 shared Deanna DwyeriD· 1 shared Elizabeth Anne MillsiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abigael P. WilliamsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 16, 2026

ARID3a-Expressing Naive B Cells in SLE have an Activated Phenotype and Transiently Express Surface CD68

Joshua W. Garton, James Randolph Sanders Hocker, Lori Garman…·Carol F. Webb

The paper identifies ARID3a and CD68 as markers of activated naive B cell precursors in SLE, showing their association with autoimmunity and disease activity.

DOI 10.64898/2026.07.10.737835

humanscRNA-seq

𝕏 PostBluesky

ImmunologyMucosal ImmunologyPeer-reviewedMar 27, 2026

ANDROGENS PROTECT ILC2S FROM FUNCTIONAL SUPPRESSION DURING INFLUENZA VIRUS INFECTION

Sapana Kadel, Reegan Miller, Anna Karlik…·Susan Kovats

This study shows that androgens protect ILC2s from functional suppression during influenza virus infection by regulating IFNGR-STAT1 signaling.

DOI 10.1016/j.mucimm.2026.03.011

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 26, 2026

Ocrelizumab Modulates Both B and T Cell Immune Capacities in Multiple Sclerosis

Qi Wu, Mikel Gurrea‐Rubio, Q. Wang…·Yang Mao‐Draayer

This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.

DOI 10.64898/2026.03.24.713043

humanflow cytometry

𝕏 PostBluesky